Apellis Pharmaceuticals CEO Cedric Francois' 2019 pay rises 5% to $4.3M
Apellis Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 22, 2020
Apellis Pharmaceuticals reported fiscal year 2019 executive compensation information on April 22, 2020.
In 2019, five executives at Apellis Pharmaceuticals received on average a compensation package of $2.7M, a 4% increase compared to previous year.
Average pay of disclosed executives at Apellis Pharmaceuticals
Cedric Francois, Chief Executive Officer, received $4.3M in total, which increased by 5% compared to 2018. 77% of Francois' compensation, or $3.3M, was in option awards. Francois also received $428K in bonus and $560K in salary.
For fiscal year 2019, the median employee pay was $311,035 at Apellis Pharmaceuticals. Therefore, the ratio of Cedric Francois' pay to the median employee pay was 14 to one.
Lucia Celona, Former Chief People Officer, received a compensation package of $3.8M. 94% of the compensation package, or $3.5M, was in option awards.
Thomas Lackner, Senior Vice President, Head of Europe, earned $2.1M in 2019.
Pascal Deschatelets, Chief Operating Officer, received $1.8M in 2019, which decreases by 2% compared to 2018.
Timothy Sullivan, Chief Financial Officer, earned $1.7M in 2019, a 100% increase compared to previous year.
Related executives
Cedric Francois
Apellis Pharmaceuticals
Chief Executive Officer
Timothy Sullivan
Apellis Pharmaceuticals
Chief Financial Officer
Pascal Deschatelets
Apellis Pharmaceuticals
Chief Scientific Officer
Lucia Celona
Apellis Pharmaceuticals
Former Chief People Officer
Thomas Lackner
Apellis Pharmaceuticals
Senior Vice President, Head of Europe
You may also like
Source: SEC filing on April 22, 2020.